Clinical messages
contracture, spasticity
The early use of botulinum toxin, as soon as spasticity is identified,
appears to be cost-neutral.Mean contracture costs for the treatment group were £817 while the costs
for the control group were £2298 (Both base case results for cost per improvement of Barthel and Action
Research Arm Test scores indicate that the intervention costs less and
is more effective.